Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 13, 2003Blood

cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity

View Full Paper
Ask AI
Bookmark
Share

Authors

JFJoseph A. FranciscoCentre for Biomedical Network Research on Rare DiseasesCCCharles G. CervenyUniversity of AucklandDMDamon L. MeyerUniversity Medical Center Groningen

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Francisco et al. (2003) studied this question.

synapsesocial.com/papers/6973f5a6c1b5f4eb45506cd3https://doi.org/10.1182/blood-2003-01-0039
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation.1993 · 66 citations
  2. 2Expression of the CD30 antigen in non-lymphoid tissues and cells2000 · 108 citations
  3. 3Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors2000 · 197 citations
  4. 4Pleiotropic effects of the CD30 ligand on CD30-expressing cells and lymphoma cell lines1994 · 304 citations
  5. 5Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis2000 · 14 citations